TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DMAC

DiaMedica Therapeutics Inc

Healthcare · Biotechnology

7.80$ +7.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

DiaMedica Therapeutics Inc (DMAC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 45 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DMAC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
58 54 49 57 53 46 39 31 57 61 53 45
48 54 47 55 51 45 37 31 56 61 52 44
2.2 4.5 2.1 14 4.1 3.0 2.6 4.1 3.3 16 4.9 5.1
46 53 47 54 50 44 36 30 55 60 51 44
0.0 0.4 0.4 0.4 0.3 0.2 0.3 0.2 0.3 0.3 0.0 0.0
2.5 3.1 2.9 3.4 4.6 5.6 4.9 4.3 5.4 5.3 5.8 6.7
2.2 2.8 2.6 3.1 4.3 5.4 4.7 4.1 5.3 5.1 5.7 6.6
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
0.9 0.9 0.7 0.8 1.2 0.9 1.5 1.3 1.9 1.5 3.3 2.8
56 51 46 53 48 41 34 27 52 56 47 38
-110 -116 -121 -126 -132 -140 -148 -155 -164 -173 -183 -193
38 38 38 38 43 43 43 43 50 47 54 54

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?